You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 8, February 25, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Medical Practice
 •Medical Practice, Other
 •Patient-Physician Relationship/ Care
 •Treatment Adherence
 •Drug Therapy
 •Adherence
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Accessing Antiretroviral Therapy Following Release From Prison

Jacques Baillargeon, PhD; Thomas P. Giordano, MD, MPH; Josiah D. Rich, MD, MPH; Z. Helen Wu, PhD; Katherine Wells, MPH; Brad H. Pollock, PhD, MPH; David P. Paar, MD

JAMA. 2009;301(8):848-857.

Context  Interruption of antiretroviral therapy (ART) during the first weeks after release from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus (HIV), and drug-resistant HIV reservoirs in the community. The extent to which HIV-infected inmates experience ART interruption following release from prison is unknown.

Objectives  To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome.

Design, Setting, and Participants  Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release.

Main Outcome Measure  Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison.

Results  Among the entire study cohort (N = 2115), an initial prescription for ART was filled by 115 (5.4%) inmates within 10 days of release (95% confidence interval [CI], 4.5%-6.5%), by 375 (17.7%) within 30 days (95% CI, 16.2%-19.4%), and by 634 (30.0%) within 60 days (95% CI, 28.1%-32.0%). In a multivariate analysis of predictors (including sex, age, race/ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days (adjusted estimated risk ratio [RR], 0.4 [95% CI, 0.2-0.8] and 0.4 [95% CI, 0.3-0.7], respectively) and 30 days (adjusted estimated RR, 0.7 [95% CI, 0.5-0.9] and 0.7 [95% CI, 0.5-0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days (adjusted estimated RR, 1.8 [95% CI, 1.2-2.7]), 30 days (1.5 [95% CI, 1.2-1.8]), and 60 days (1.3 [95% CI, 1.1-1.5]). Inmates released on parole were more likely to fill a prescription within 30 days (adjusted estimated RR, 1.3 [95% CI, 1.1-1.6]) and 60 days (1.5 [95% CI, 1.4-1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days (adjusted estimated RR, 3.1 [95% CI, 2.0-4.9]), 30 days (1.8 [95% CI, 1.4-2.2]), and 60 days (1.3 [95% CI, 1.1-1.4]).

Conclusion  Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.


Author Affiliations: Department of Preventive Medicine and Community Health (Dr Baillargeon), Correctional Managed Care Division (Drs Baillargeon and Paar), Department of Obstetrics and Gynecology (Dr Wu), and Department of Internal Medicine (Dr Paar), University of Texas Medical Branch, Galveston; Department of Medicine, Baylor College of Medicine, and the Houston Center for Quality of Care and Utilization Studies, Michael E. DeBakey VA Medical Center, Houston, Texas (Dr Giordano); Department of Medicine, Brown Medical School, Providence, Rhode Island (Dr Rich); Texas HIV Medication Program, Department of State Health Services, Austin (Ms Wells); and Department of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio (Dr Pollock).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Treatment for Individuals With HIV/AIDS Following Release From Prison
Ingrid A. Binswanger and Hal S. Wortzel
JAMA. 2009;302(2):147.
EXTRACT | FULL TEXT  

Treatment for Individuals With HIV/AIDS Following Release From Prison
Keith Barton
JAMA. 2009;302(2):147-148.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment for Individuals With HIV/AIDS Following Release From Prison
Binswanger and Wortzel
JAMA 2009;302:147-147.
FULL TEXT  

Treatment for Individuals With HIV/AIDS Following Release From Prison
Barton
JAMA 2009;302:147-148.
FULL TEXT  

Accessing ART After Imprisonment
JWatch Infect. Diseases 2009;2009:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.